Deal or Case news
Ginkgo Bioworks, Inc. ("Ginkgo"), the organism company, announced it has signed a purchase agreement to acquire Dutch DNA Biotech B.V. ("Dutch DNA").

Dutch DNA is a company based in Utrecht, Netherlands with a proprietary platform technology focused on the development of fungal strains and fermentation processes for the production of proteins and organic acids.

This news follows a period of momentum and growth for Ginkgo. On 11 May 2021, Ginkgo announced it has agreed to a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), a publicly traded special purpose acquisition company, that will result in Ginkgo becoming a publicly-listed company. The transaction implies a pre-money equity valuation for Ginkgo of $15.0 billion, and is expected to provide up to $2.5 billion of gross cash proceeds.

The core deal team consisted of Jeanine Evertse, Isabelle Wilcke, Eline van Marle, Mariebelle Timmermans, Rebecca Runa Pinto – Noome and Ruud Smits (Corporate M&A), Aira Scheijvens, Josephine de Graaf (Corporate M&A Notarial), Nina Kielman, Alissia Sudibyo (Tax).

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.